We are live on ! Find out more
SONM icon

DNA X Inc

40 hedge funds and large institutions have $34.3M invested in DNA X Inc in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 3

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

44% more capital invested

Capital invested by funds: $23.8M → $34.3M (+$10.5M)

21% more funds holding

Funds holding: 3340 (+7)

0% more ownership

Funds ownership: 0.02%0.03% (+0%)

Holders
40
Holders Change
+7
Holders Change %
+21.21%
% of All Funds
0.79%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
14
Increased
18
Reduced
3
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
51
Two Sigma Investments
New York
-$70K -13 Closed
OAM
52
Oxford Asset Management
United Kingdom
-$41K -8 Closed
Janus Henderson Group
53
Janus Henderson Group
United Kingdom
-$36K -7 Closed
Victory Capital Management
54
Victory Capital Management
Texas
-$2K

SONM Hedge Fund Activity: Q4 2019 in Review

40 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q4 2019, worth a combined $34.3M — up 44% from $23.8M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new SONM positions and 7 closed out — a net gain of 7 holders — while 18 added to existing stakes and 3 trimmed.

The largest buyer was Cannell Capital, opening a new position worth an estimated $1.56M. The largest seller was Wasatch Advisors, exiting entirely with an estimated $1.61M sold.

  • 40 institutional investors held DNA X Inc (SONM) as of Q4 2019, up from 33 in Q3 2019.
  • Funds reported $34.3M of DNA X Inc stock for Q4 2019, up 44% quarter-over-quarter.
  • 14 funds opened new DNA X Inc positions in Q4 2019 and 7 closed out, a net change of +7 holders.
  • The largest DNA X Inc buyer in Q4 2019 was Cannell Capital, an estimated $1.56M added.
  • The largest DNA X Inc seller in Q4 2019 was Wasatch Advisors, an estimated $1.61M sold.

Based on aggregated 13F filings for Q4 2019.